141 related articles for article (PubMed ID: 2553991)
1. Antibodies against the human papillomavirus type 16 early proteins in human sera: correlation of anti-E7 reactivity with cervical cancer.
Jochmus-Kudielka I; Schneider A; Braun R; Kimmig R; Koldovsky U; Schneweis KE; Seedorf K; Gissmann L
J Natl Cancer Inst; 1989 Nov; 81(22):1698-704. PubMed ID: 2553991
[TBL] [Abstract][Full Text] [Related]
2. Detection of antibodies to the E4 or E7 proteins of human papillomaviruses (HPV) in human sera by western blot analysis: type-specific reaction of anti-HPV 16 antibodies.
Jochmus I; Bouwes Bavinck JN; Gissmann L
Mol Cell Probes; 1992 Aug; 6(4):319-25. PubMed ID: 1326715
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of antibodies to L1, L2, E4 and E7 gene products of human papillomavirus types 6b, 16 and 18 among cervical cancer patients and controls.
Köchel HG; Monazahian M; Sievert K; Höhne M; Thomssen C; Teichmann A; Arendt P; Thomssen R
Int J Cancer; 1991 Jul; 48(5):682-8. PubMed ID: 1649138
[TBL] [Abstract][Full Text] [Related]
4. Association of the antibodies against human papillomavirus 16 E4 and E7 proteins with cervical cancer positive for human papillomavirus DNA.
Onda T; Kanda T; Zanma S; Yasugi T; Watanabe S; Kawana T; Ueda K; Yoshikawa H; Taketani Y; Yoshiike K
Int J Cancer; 1993 Jun; 54(4):624-8. PubMed ID: 8390409
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to the E4, E6, and E7 proteins of human papillomavirus (HPV) type 16 in patients with HPV-associated diseases and in the normal population.
Müller M; Viscidi RP; Ulken V; Bavinck JN; Hill PM; Fisher SG; Reid R; Munoz N; Schneider A; Shah KV
J Invest Dermatol; 1995 Jan; 104(1):138-41. PubMed ID: 7798632
[TBL] [Abstract][Full Text] [Related]
6. Independent association of antibodies against human papillomavirus type 16 E1/E4 and E7 proteins with cervical cancer.
Kanda T; Onda T; Zanma S; Yasugi T; Furuno A; Watanabe S; Kawana T; Sugase M; Ueda K; Sonoda T
Virology; 1992 Oct; 190(2):724-32. PubMed ID: 1325704
[TBL] [Abstract][Full Text] [Related]
7. Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.
Ghosh AK; Smith NK; Stacey SN; Glew SS; Connor ME; Arrand JR; Stern PL
Int J Cancer; 1993 Feb; 53(4):591-6. PubMed ID: 8382193
[TBL] [Abstract][Full Text] [Related]
8. Identification of antibodies against human papillomavirus type 16 E6 and E7 proteins in sera of patients with cervical neoplasias.
Sasagawa T; Inoue M; Tanizawa O; Yutsudo M; Hakura A
Jpn J Cancer Res; 1992 Jul; 83(7):705-13. PubMed ID: 1325428
[TBL] [Abstract][Full Text] [Related]
9. Detection of human papillomavirus type 16 DNA and of antibodies to human papillomavirus type 16 proteins in children.
Mund K; Han C; Daum R; Helfrich S; Müller M; Fisher SG; Schiller JT; Gissmann L
Intervirology; 1997; 40(4):232-7. PubMed ID: 9612724
[TBL] [Abstract][Full Text] [Related]
10. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer.
Meschede W; Zumbach K; Braspenning J; Scheffner M; Benitez-Bribiesca L; Luande J; Gissmann L; Pawlita M
J Clin Microbiol; 1998 Feb; 36(2):475-80. PubMed ID: 9466762
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against high-risk human papillomavirus proteins as markers for invasive cervical cancer.
Combes JD; Pawlita M; Waterboer T; Hammouda D; Rajkumar T; Vanhems P; Snijders P; Herrero R; Franceschi S; Clifford G
Int J Cancer; 2014 Nov; 135(10):2453-61. PubMed ID: 24729277
[TBL] [Abstract][Full Text] [Related]
12. The association of human papillomavirus antibodies with cervical cancer risk.
Mandelson MT; Jenison SA; Sherman KJ; Valentine JM; McKnight B; Daling JR; Galloway DA
Cancer Epidemiol Biomarkers Prev; 1992; 1(4):281-6. PubMed ID: 1338895
[TBL] [Abstract][Full Text] [Related]
13. High prevalence of serum antibodies to Ras and type 16 E4 proteins of human papillomavirus in patients with precancerous lesions of the uterine cervix.
Pedroza-Saavedra A; Cruz A; Esquivel F; De La Torre F; Berumen J; Gariglio P; Gutiérrez L
Arch Virol; 2000; 145(3):603-23. PubMed ID: 10795526
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.
Bleul C; Müller M; Frank R; Gausepohl H; Koldovsky U; Mgaya HN; Luande J; Pawlita M; ter Meulen J; Viscidi R
J Clin Microbiol; 1991 Aug; 29(8):1579-88. PubMed ID: 1722219
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of serum IgG antibodies for the E7 and L2 proteins of human papillomavirus type 16 in cervical cancer patients and controls.
Paez CG; Yaegashi N; Sato S; Yajima A
Tohoku J Exp Med; 1993 Jun; 170(2):113-21. PubMed ID: 8266324
[TBL] [Abstract][Full Text] [Related]
16. Epitope mapping of the human papillomavirus type 16 E4 protein by means of synthetic peptides.
Suchánková A; Krchnák V; Vágner J; Hamsíková E; Krcmár M; Ritterová L; Vonka V
J Gen Virol; 1992 Feb; 73 ( Pt 2)():429-32. PubMed ID: 1371544
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to human papillomavirus type-16 in human sera as revealed by the use of prokaryotically expressed viral gene products.
Köchel HG; Sievert K; Monazahian M; Mittelstädt-Deterding A; Teichmann A; Thomssen R
Virology; 1991 Jun; 182(2):644-54. PubMed ID: 1850922
[TBL] [Abstract][Full Text] [Related]
18. Antibodies prevalence against HPV-6b and -16 recombinant fusion proteins in Korean patients with cervical neoplasia.
Park SN; Yoon HS; Choi YK; Choe IS; Chung RP; Chee YH; Namkoong SE; Kim SJ; Park JS
J Obstet Gynaecol (Tokyo 1995); 1995 Dec; 21(6):609-17. PubMed ID: 8640473
[TBL] [Abstract][Full Text] [Related]
19. Serological assays for the detection of HPV antibodies.
Galloway DA
IARC Sci Publ; 1992; (119):147-61. PubMed ID: 1330907
[TBL] [Abstract][Full Text] [Related]
20. Identification of antibodies against human papillomavirus type 16 E4 and E7 proteins in sera of patients with cervical neoplasias.
Stoian M; Repanovici R
Rev Roum Virol; 1994; 45(3-4):185-92. PubMed ID: 7619739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
